Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and the health of people who use drugs: What is and what could be?
Jason Grebely, Magdalena Cerdá, Tim Rhodes
International Journal of Drug Policy (2020) Vol. 83, pp. 102958-102958
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis
Evan B. Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 5, pp. 426-445
Open Access | Times Cited: 94
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework
Tribesty Nguyen, Jane A. Buxton
International Journal of Drug Policy (2021) Vol. 93, pp. 103236-103236
Open Access | Times Cited: 63
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic
Wendy Wing-Yee Chong, Zeynep Ilgaz Acar, Meghan Lee West, et al.
Cannabis and Cannabinoid Research (2022) Vol. 7, Iss. 5, pp. 591-602
Open Access | Times Cited: 42
The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services
Yesenia Aponte-Meléndez, Pedro Mateu‐Gelabert, Chunki Fong, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 52
Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations
Bruce Wallace, Rory A. Hills, Jake Rothwell, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 4, pp. 734-746
Closed Access | Times Cited: 48
Opioid Treatment Programs, Telemedicine and COVID-19: A Scoping Review
Brian Chan, Christina Bougatsos, Kelsey C. Priest, et al.
Substance Abuse (2021) Vol. 43, Iss. 1, pp. 539-546
Closed Access | Times Cited: 48
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs
Joanna M Kesten, Adam Holland, Myles-Jay Linton, et al.
International Journal of Drug Policy (2021) Vol. 98, pp. 103391-103391
Open Access | Times Cited: 45
A Qualitative Study of Patient Experiences with Telemedicine Opioid use Disorder Treatment during COVID-19
Rachel Lockard, Kelsey C. Priest, Jessica Gregg, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 1155-1162
Closed Access | Times Cited: 31
Increased solitary drug use during COVID-19: An unintended consequence of social distancing
Kristin E. Schneider, Sean T. Allen, Saba Rouhani, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103923-103923
Open Access | Times Cited: 31
Big data and predictive modelling for the opioid crisis: existing research and future potential
Chrianna Bharat, Matthew Hickman, Sebastiano Barbieri, et al.
The Lancet Digital Health (2021) Vol. 3, Iss. 6, pp. e397-e407
Closed Access | Times Cited: 35
The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals
Colleen Mistler, Christine M. Curley, Aviana O. Rosen, et al.
Journal of Community Health (2021) Vol. 46, Iss. 5, pp. 960-966
Open Access | Times Cited: 33
The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study
Joe Schofield, Joshua Dumbrell, Catriona Matheson, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study
Heather Valerio, Maryam Alavi, Anna Conway, et al.
International Journal of Drug Policy (2022) Vol. 105, pp. 103706-103706
Closed Access | Times Cited: 25
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
Daniyar Aldabergenov, Laura Reynolds, Jenny Scott, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103877-103877
Open Access | Times Cited: 25
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency
Marion Selfridge, Kiffer G. Card, Taylor Kandler, et al.
International Journal of Drug Policy (2022) Vol. 105, pp. 103709-103709
Open Access | Times Cited: 24
“It’s just a perfect storm”: Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances
Annie Foreman-Mackey, Jessica Xavier, Jenny Corser, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
“No home to take methadone to”: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston
Miriam Harris, Audrey M. Lambert, Ariel Maschke, et al.
Journal of Substance Abuse Treatment (2021) Vol. 135, pp. 108655-108655
Open Access | Times Cited: 31
Harm Reduction in Sexual Medicine
Andrea Sansone, Erika Limoncin, Elena Colonnello, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 1, pp. 3-22
Closed Access | Times Cited: 29
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
Alex S. Bennett, Tarlise Townsend, Luther Elliott
International Journal of Drug Policy (2021) Vol. 101, pp. 103554-103554
Open Access | Times Cited: 29
Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study
Kirsten M. A. Trayner, Andrew McAuley, Norah Palmateer, et al.
Drug and Alcohol Dependence (2022) Vol. 232, pp. 109263-109263
Open Access | Times Cited: 22
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022
Eshan U. Patel, Jacqueline E. Rudolph, Kenneth A. Feder, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104746-104746
Closed Access
“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
Anna Conway, Carla Treloar, Sione Crawford, et al.
International Journal of Drug Policy (2023) Vol. 114, pp. 103998-103998
Open Access | Times Cited: 10
Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States
Kristin E. Schneider, Emily Martin, Sean T. Allen, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104371-104371
Closed Access | Times Cited: 3
Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Lucas Wiessing, Vana Sypsa, Adrian Abagiu, et al.
AIDS and Behavior (2022) Vol. 27, Iss. 4, pp. 1140-1153
Open Access | Times Cited: 15
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study
Kari Lancaster, Sandra Gendera, Carla Treloar, et al.
Contemporary Drug Problems (2022) Vol. 50, Iss. 1, pp. 105-120
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top